Aptamers and antibodies: rivals or allies in cancer targeted therapy?
The goal of an efficacious cancer therapy is to specifically target diseased cells at high accuracy while sparing normal, healthy cells. Over the past three decades, immunotherapy, based on the use of monoclonal antibodies (mAbs) directed against tumor-associated antigens, to inhibit their oncogenic...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Book |
| Published: |
Open Exploration Publishing Inc.,
2021-02-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|